In this quartery column in association with Ophthalmic Women Leaders, Beiting launches the series with
five pearls for anyone seeking more exposure from the podium.
Author: ModernMedecine
Corneal ulcers respond to corneal collagen crosslinking therapy
Results from patients treated for refractory ulcers due to infectious keratitis show corneal collagen
crosslinking is an effective intervention that results in rapid and complete healing.
Transcleral or endoscopic cyclophotocoagulation support glaucoma therapy
Results from a retrospective review of outcomes after transcleral or endoscopic cyclophotocoagulation
for a variety of glaucoma conditions provide additional information on the efficacy and safety of these procedures,
including in select subgro…
Chicago awaits ASCRS attendees
The annual American Society of Cataract and Refractive Surgery Symposium on Cataract, IOL, and
Refractive Surgery will be held here Friday, April 20, to Tuesday, April 24.
Piecing together your retirement puzzle
When meeting with pre-retirees as well as current retirees, one of the most common areas of concern,
apprehension, and (at times) outright fear, is whether they will run out of money during retirement.
Paying the piper
The author tackles the issue of high levels of student loan debt.
Counterfeit bevacizumab found at oncology practices
Retina specialists who use compounded bevacizumab off-label to treat wet age-related macular
degeneration are being warned that counterfeit vials of the cancer drug have turned up in oncology practices in the
United States.
Ophthalmology Times’ coverage of comparison of age-related macular degeneration treatments trials coverage captures Neal award
Ophthalmology Times was honored for Best News Coverage at the 58th annual Jesse H. Neal National
Business Journalism Awards competition recognizing editorial excellence.
Beta-blocker explored
Propanolol, a nonselective beta-blocker, is an effective treatment for infantile hemangiomas that
might be used in place of steroids in selected cases.
Inlay aids vision
A hydrogel corneal inlay designed to treat presbyopia seems, based on early clinical results, to
improve near vision markedly without significant safety concerns.